Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Selectivity interaction (KinomeScan (DiscoverX)) EUB0000740a ADCK4
Assay data:1 Tested
SummaryRelated BioAssays by Target
ADCK4 DiscoveRx kinase panel
KinomeScan assay: inhibition of ADCK4
Assay data:1 Active, 108 Tested
SummaryCompounds, ActiveRelated BioAssays by Target
Inhibition of human ADCK4 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control
Inhibition of DNA-tagged human ADCK4 assessed as percent of control at 50000 nM by qPCR analysis relative to control
Inhibition of human ADCK4 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control
Binding affinity to wild-type human full length ADCK4 (M1 to S544 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of wild-type human full length ADCK4 (M1 to S544 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control
Inhibition of wild-type human full length ADCK4 (M1 to S544 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control
Binding affinity to wild-type human full length ADCK4 (M1 to S544 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control
Inhibition of wild-type human full length ADCK4 (M1 to S544 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control
RNAi screen for vemurafenib enhancer genes in BRAFV600 melanoma - Primary Screen
Assay data:790 Active, 18119 Tested
Summary
Inhibition of wild-type human full length ADCK4 (M1 to S544 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control
Assay data:2 Tested
Inhibition of wild-type human full length ADCK4 (M1 to S544 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control
Inhibition of wild-type human full length ADCK4 (M1 to S544 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control
Binding affinity to wild-type human full length ADCK4 (M1 to S544 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on